V
Vynca
Uniquely collaborative company working at the intersection of software and medicine
About Vynca
Vynca operates in the healthcare sector, specializing in advance care planning solutions. The company provides a platform that ensures patients' end-of-life wishes are documented and accessible across various healthcare settings, including hospitals, ICU, and post-acute care facilities. Vynca serves a diverse range of clients such as Accountable Care Organizations (ACOs), payers, providers, and state registries. The business model is based on a subscription service where healthcare providers and organizations pay for access to Vynca's platform and services. This model allows Vynca to generate recurring revenue while providing measurable improvements in patient care, such as a 37% reduction in hospital admissions and a 59% reduction in ICU admissions when their platform is utilized. The company operates primarily in the United States and aims to enhance the quality of end-of-life care by prioritizing patient choices and coordinating care across the healthcare continuum.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2022 | $30M | $120M | OCA Ventures · Generator Ventures · First Trust Capital Partners · The 4100 Group | ↗ |
| SERIES B✓Equity / VC | Jun 2019 | $10M | $41M | OCA Ventures · Generator Ventures · Spectrum Health Ventures | — |
Growth signals
Latest recorded traffic for Vynca is 150 monthly website visits, down 91.2% over the last three months. Vynca's team grew 20.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
MedTech Innovator
Series A3 investors entered at this stage
OCA Ventures
Generator Ventures
Spectrum Health Ventures
Series B and later3 investors entered at this stage
Questa Capital Management
First Trust Capital Partners- TGThe 4100 Group
Other known investors3 additional known investors
- ACAphelion Capital
StartX
Taiwan Startup Stadium
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vynca on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vynca’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.